aminoven infant 10 % otopina za infuziju
fresenius kabi d.o.o., radnička cesta 37a, zagreb, hrvatska - izoleucin leucin lizinacetat metionin fenilalanin treonin triptofan valin arginin histidin glicin alanin prolin serin taurin acetiltirozin acetilcistein malatna kiselina - otopina za infuziju - 10% - urbroj: 1 litra otopine za infuziju sadržava: 8,00 g izoleucina, 13,00 g leucina, 12,00 g lizin acetata (8,51 g lizina), 3,12 g metionina, 3,75 g fenilalanina, 4,40 g treonina, 2,01 g triptofana, 9,00 g valina, 7,50 g arginina, 4,76 g histidina, 4,15 g glicina, 9,30 g alanina, 9,71 g prolina, 7,67 g serina, 0,40 g taurina, 5,176 g acetil-tirozina (4,20 g tirozina), 0,70 g acetil-cisteina (0,52 g cisteina) i 2,62 g jabučne kiseline
ultomiris
alexion europe sas - ravulizumab - hemoglobinuria, paroxysmal - selektivni imunosupresivi - paroxysmal nocturnal haemoglobinuria (pnh)ultomiris is indicated in the treatment of adult and paediatric patients with a body weight of 10 kg or above with pnh:- in patients with haemolysis with clinical symptom(s) indicative of high disease activity. - in patients who are clinically stable after having been treated with eculizumab for at least the past 6 months (see section 5. atypical haemolytic uremic syndrome (ahus)ultomiris is indicated in the treatment of patients with a body weight of 10 kg or above with ahus who are complement inhibitor treatment-naïve or have received eculizumab for at least 3 months and have evidence of response to eculizumab (see section 5. generalized myasthenia gravis (gmg)ultomiris is indicated as an add-on to standard therapy for the treatment of adult patients with gmg who are anti-acetylcholine receptor (achr) antibody-positive. neuromyelitis optica spectrum disorder (nmosd)ultomiris is indicated in the treatment of adult patients with nmosd who are anti-aquaporin 4 (aqp4) antibody-positive (see section 5. ultomiris is indicated in the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (pnh):- in patients with haemolysis with clinical symptom(s) indicative of high disease activity. - in patients who are clinically stable after having been treated with eculizumab for at least the past 6 months. ultomiris is indicated in the treatment of adult patients with atypical haemolytic uremic syndrome (ahus) who are complement inhibitor treatment-naïve or have received eculizumab for at least 3 months and have evidence of response to eculizumab.
fluimukan direkt 600 mg oralni prašak u vrećici
sandoz d.o.o., maksimirska 120, zagreb, hrvatska - acetilcistein - oralni prašak u vrećici - 600 mg - urbroj: svaka vrećica sadrži 600 mg acetilcisteina
acetilcistein zambon 600 mg šumeće tablete
zambon s.p.a., via lillo del duca, 10, bresso (milano), italija - acetilcistein - Šumeća tableta - urbroj: jedna šumeća tableta sadrži 600 mg acetilcisteina
caffetin 250 mg + 210 mg + 50 mg + 10 mg tableta
druŠtvo "alkaloid" d.o.o. podgorica - paracetamol, propifenazon, kofein, kodein - tableta - 250 mg + 210 mg + 50 mg + 10 mg
yasnal 10 mg filmom obložene tablete
krka - farma d.o.o., radnička cesta 48, zagreb - donepezilklorid - filmom obložena tableta - 10 mg - urbroj: svaka filmom obložena tableta sadrži 10 mg donepezilklorida
yasnal 5 mg filmom obložene tablete
krka - farma d.o.o., radnička cesta 48, zagreb - donepezilklorid - filmom obložena tableta - 5 mg - urbroj: svaka filmom obložena tableta sadrži 5 mg donepezilklorida
yasnal 5 mg/1 tableta filmom obložena tableta
krka farma d.o.o. sarajevo - donepezil - filmom obložena tableta - 5 mg/1 tableta - 1 filmom obložena tableta sadrži: 5 mg donepezila (u obliku donepezil hlorida)
yasnal 10 mg/1 tableta filmom obložena tableta
krka farma d.o.o. sarajevo - donepezil - filmom obložena tableta - 10 mg/1 tableta - 1 filmom obložena tableta sadrži: 10 mg donepezila (u obliku donepezil hlorida)
respimucil 600 mg granule za oralnu otopinu u vrećici
zambon s.p.a., via lillo del duca, 10, bresso (milano), italija - acetilcistein - granule za oralnu otopinu u vrećici - urbroj: jedna vrećica sadrži 600 mg acetilcisteina